Results 11 to 20 of about 2,473,811 (360)

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation

open access: yesFrontiers in Immunology, 2021
Autoimmune uveitis is a sight-threatening ocular inflammatory condition in which the retina and uveal tissues become a target of autoreactive immune cells.
Yoko Okunuki   +3 more
doaj   +1 more source

Comprehensive single-cell analysis reveals novel anergic antigen-presenting cell subtypes in human sepsis

open access: yesFrontiers in Immunology, 2023
BackgroundSepsis is a life-threatening condition with high mortality. A few studies have emerged utilizing single-cell RNA sequencing (scRNA-seq) to analyze gene expression at the single-cell resolution in sepsis, but a comprehensive high-resolution ...
Tuo Zhang   +17 more
doaj   +1 more source

Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer

open access: yesCells, 2022
Dendritic cells (DCs) are a unique myeloid cell lineage that play a central role in the priming of the adaptive immune response. As such, they are an attractive target for immune oncology based therapeutic approaches.
Enrica Marmonti   +2 more
doaj   +1 more source

Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer

open access: yesbioRxiv, 2021
Multiple recent single cell RNA sequencing (scRNA-seq) studies have identified a unique cancer-associated fibroblast (CAF) population in pancreatic ductal adenocarcinoma (PDA) called antigen-presenting CAFs (apCAFs).
Huocong Huang   +3 more
semanticscholar   +1 more source

Tumor Antigen Presentation by Dermal Antigen-Presenting Cells [PDF]

open access: yesJournal of Investigative Dermatology, 2000
Several phenotypes of antigen-presenting cells are present in the dermis, where they presumably function to present encountered antigens for immune responses. This study examined the ability of dermal antigen-presenting cells to present tumor-associated antigens for the induction of in vivo antitumor immunity.
Edward Miranda   +8 more
openaire   +3 more sources

Antigen Presentation by Vascular Cells [PDF]

open access: yesFrontiers in Immunology, 2017
Antigen presentation by cells of the vessel wall may initiate rapid and localized memory immune responses in peripheral tissues. Peptide antigens displayed on major histocompatibility complex (MHC) molecules on the surface of endothelial cells (ECs) can be recognized by T cell receptors on circulating effector memory T cells (TEM), triggering both ...
Rebecca Liu   +3 more
openaire   +4 more sources

Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain

open access: yesJournal of Neuroinflammation, 2020
Background Many lines of evidence suggest that accumulation of aggregated alpha-synuclein (αSYN) in the Parkinson’s disease (PD) brain causes infiltration of T cells.
Jinar Rostami   +7 more
semanticscholar   +1 more source

Daratumumab prevents programmed death ligand‐1 expression on antigen‐presenting cells in de novo multiple myeloma

open access: yesCancer Medicine, 2020
Background Daratumumab (Dara), an anti‐CD38 monoclonal antibody, has an immunologic mechanism of action through targeting of CD38 expressing immune cells in patients with multiple myeloma (MM). Furthermore, it was recently shown that CD38 upregulation in
Nicolas Stocker   +6 more
doaj   +1 more source

Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus

open access: yesMicrobiome, 2023
Background Cervicovaginal inflammation has been linked to negative reproductive health outcomes including the acquisition of HIV, other sexually transmitted infections, and cervical carcinogenesis. While changes to the vaginal microbiome have been linked
Christina Farr Zuend   +20 more
doaj   +1 more source

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

open access: yesFrontiers in Oncology, 2021
The development of immunotherapeutic methods for the treatment of oncological diseases have made it possible to improve the effectiveness of standard therapies.
Ivan Y. Filin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy